The Oklahoma House on Monday signed off on new protections for residents living with epilepsy, voting 63-32 to advance House Bill 4294. The measure would bar insurers from canceling or refusing to renew coverage solely because someone has an epilepsy diagnosis, and it would require coverage for certain devices and surgeries used to control seizures. Supporters are pitching the change as a parity move that could open up access to treatments some patients describe as lifesaving.
As reported by News9, the vote followed debate on the House floor and came after earlier committee approval this month. According to LegiScan, Rep. Daniel Pae is listed as the bill's primary sponsor in the House, with Sen. Brenda Stanley serving as the principal author on the Senate side. The measure moved through Insurance and Commerce committee stops before making it to the floor for a final tally.
What the bill would require
Under the current floor version of HB4294, all individual and group health insurance policies that provide medical and surgical benefits would have to offer the same coverage and benefits to people diagnosed with epilepsy as they do to people without the condition. The proposal explicitly prohibits insurers from terminating or refusing to renew coverage solely because of an epilepsy diagnosis.
The bill also directs insurers to cover medically necessary neurostimulation devices when they are prescribed by a licensed physician who is actively treating the enrollee. The floor text sets an effective date of November 1, 2026, and the full language is available in the Legislature's floor document from the Oklahoma Legislature.
Why advocates say it matters
Advocates argue that HB4294 could widen access to high-cost, device-based treatments, including vagus nerve stimulators and responsive neurostimulation devices, that can reduce seizures and lower the risk of sudden unexpected death in epilepsy (SUDEP). The Epilepsy Foundation provides information on SUDEP and prevention strategies, materials that supporters pointed to during legislative hearings.
According to coverage by News9, the measure is expected to affect an estimated more than 41,000 Oklahomans living with epilepsy, a figure attributed to the Epilepsy Foundation of Oklahoma.
Next steps
With the House vote in the books, HB4294 now heads across the rotunda to the Oklahoma Senate, where Sen. Brenda Stanley is listed as the principal Senate author. The bill's committee history shows it has already moved through Insurance and Commerce and Economic Development Oversight committees this month. LegiScan is tracking the running history and vote log for HB4294 as it advances.
Legal implications
If enacted, HB4294 would create a new statutory section in Title 36 of the Oklahoma Statutes and place explicit parity and non-discrimination obligations on private insurers that offer medical and surgical benefits. Carriers would likely need to update medical policy criteria and prior-authorization rules to comply with the requirement to cover medically necessary neurostimulation devices when they are prescribed by a treating physician.
The bill's floor text spells out the codification details and effective date; those specifics are laid out in the floor document from the Oklahoma Legislature.
For Oklahomans who depend on device-based epilepsy treatments and the advocates who have been pushing for these protections, the Senate calendar and any technical amendments will be the next things to watch. Committee filings and statements from stakeholders are likely to shape how the measure fares in the upper chamber.
